R. Alan B. Ezekowitz, M.D. |
|
|
Center of ExcellenceMassachusetts General Hospital for Children, Partners Healthcare SystemStateMASpecialtyPediatrics & Immunology |
|
Dr. Ezekowitz is Chief of the Pediatric Services at Massachusetts General Hospital for Children and the Partners HealthCare System. He is also Head of the Laboratory of Developmental Immunology at Massachusetts General Hospital and the Charles Wilder Professor of Pediatrics at Harvard Medical School.
Immunodeficiency is the clinical area that interests Dr. Ezekowitz the most. Furthermore, he has played an important role in defining advances in the treatment and management of patients with vascular anomalies of infancy and childhood. Dr. Ezekowitz pioneered efforts that defined the use of interferon gamma in prophylaxis for Chronic Granulomatous Disease. His basic science interests are predominantly in the area of innate immunity. Dr. Ezekowitz combines clinical expertise with a unique background in basic and translational research.
Dr. Ezekowitz obtained his medical training at the University of Cape Town in South Africa and the University of Oxford where he obtained a Doctor of Philosophy degree in macrophage cell and molecular biology. He completed a Postdoctoral Fellowship at the Sir William Dunn School of Pathology in Oxford. In 1984, he began an 11-year tenure at the Children?s Hospital in Boston, where he obtained further pediatric training and completed a second Postdoctoral Fellowship in the division of Hematology/Oncology. He then began his own independent research effort and became the director of the General Clinic Research Center at Children?s Hospital.
He is a member of many medical societies and associations such as; American Pediatric Society, American Society of Cell Biology, American Society of Hematology, American Society for Clinical Investigation, Fellow of the Infectious Diseases Society of America, Society for Pediatric Research, Society for Leukocyte Biology and American Association of Physicians. In addition he is a reviewer for Cell, Nature, Science, Immunity, Journal of Experimental Medicine, New England Journal of Medicine and on the editorial board for Microbes and Infection.
|
|








